We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

QTWO:NYSEQ2 Holdings, Inc. Analysis

Data as of 2026-07-20 - not real-time

$54.86

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Q2 Holdings trades at $54.86, roughly 19% below its DCF‑derived fair value of $67.82, suggesting notable upside potential. The stock’s RSI sits at 64.9, indicating modest overbought pressure, while a bullish MACD histogram (+0.49) points to short‑term momentum. However, the 30‑day volatility of 45% and a decreasing volume trend signal heightened price swings and waning buying interest. Fundamentally, revenue grew 14% YoY to $821.6 M, operating margins are healthy at 13%, and free cash flow exceeds $179 M, supporting a forward PE of 16.8 versus a trailing PE of 48.5.
The sector—U.S. software‑application—carries medium regulatory exposure given its focus on financial institutions, but the company’s low debt‑to‑equity (56%) and solid cash position mitigate balance‑sheet risk. Analyst consensus remains a “Buy” with a median price target of $74, reinforcing the view that the market is undervaluing the firm’s growth trajectory. Overall, the blend of intrinsic undervaluation, strong cash generation, and expanding fintech demand outweighs the near‑term volatility concerns.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD with positive histogram
  • RSI approaching overbought levels
  • Decreasing volume indicating weakening momentum

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • 14% YoY revenue growth and expanding margins
  • Forward PE compression to 16.8 versus trailing 48.5
  • DCF upside of ~31% and analyst buy consensus

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Secular demand for digital banking and fintech platforms
  • Strong free cash flow generation and solid cash balance
  • Moderate leverage and low beta reducing market sensitivity

Key Metrics & Analysis

Financial Health

Revenue Growth14.10%
Profit Margin8.99%
P/E Ratio48.5
ROE12.77%
ROA3.17%
Debt/Equity56.22
P/B Ratio5.6
Op. Cash Flow$214.3M
Free Cash Flow$179.9M
Industry P/E32.8

Technical Analysis

TrendNeutral
RSI64.9
Support$40.79
Resistance$56.83
MA 20$49.69
MA 50$47.61
MA 200$57.40
MACDBullish
VolumeDecreasing
Fear & Greed Index87.91

Valuation

Fair Value$67.82
Target Price$72.18
Upside/Downside31.57%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta0.49
Volatility45.27%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.